This study gives an overview of the genetic diversity of *S. aureus* involved in the bovine mastitis improving knowledge for monitoring of this pathogen.

1. Introduction {#sec1-toxins-10-00247}
===============

*Staphylococcus aureus* continues to be one of the most prevalent pathogens causing intramammary infections (IMI) in dairy cows. It's a worldwide pathogen recognized as a cause of subclinical infections, resulting in increased somatic cell count (SCC), but may also cause clinical mastitis. Staphylococcal mastitis is a major problem in dairy industry, affecting animal health and causing economic losses of up to €300 per cow per year, due to the reduced milk quality and production \[[@B1-toxins-10-00247],[@B2-toxins-10-00247]\]. The main reservoir of *S. aureus* seems to be the infected quarter, and transmission usually occurs from cow to cow during milking.

Successful infection depends on virulence factors produced by *S. aureus.* A wide spectrum of secreted and cell surface-associated virulence factors can be expressed to promote adhesion to the host extracellular matrix components, damage host cells, and fight the immune system \[[@B3-toxins-10-00247]\]. At least 25 different toxins (such as enterotoxins SEA to SEQ, toxic shock syndrome toxin-1 TSST-1, exfoliative toxins Eta, Etb), 15 microbial surface components recognizing adhesive matrix molecules, which are important for adhesion to tissues (such as clumping factor A *clfA*, intercellular adhesion genes *icaA* and *icaD*), 20 immune evasion molecules (such as protein A, coagulase, haemolysins and leucocidins, factors associated with suppressing innate immunity) and several other *S. aureus* virulence factors are known. Some virulence factors are expressed by genes that are located on mobile genetic elements called pathogenicity islands (i.e., TSST and some enterotoxins) or lysogenic bacteriophages (i.e., Panton-Valentine Leucocidin, PVL) and others such as the staphylococcal complement inhibitor, *scn*, the chemotaxis inhibitory protein, *chp*, and staphylokinase, *sak*, are integrated in the bacterial chromosome \[[@B4-toxins-10-00247]\]. Furthermore, *S. aureus* can also acquire the staphylococcal cassette chromosome SCC*mec*, giving rise to methicillin-resistant *S. aureus* (MRSA) \[[@B5-toxins-10-00247]\]. In fact, the expression of the *mecA* or *mecC* gene in *S. aureus* confers resistance to most of β-lactams, drugs which are frequently used for treatment of mastitis \[[@B6-toxins-10-00247]\].

The determination of the origin of the *S. aureus* isolates involved in the aetiology of bovine mastitis is highly relevant from the epidemiological point of view. In such a context, the precise characterization of this pathogen provides monitoring of the bacterial strains dissemination among animal populations.

Over the past two decades, a wide range of phenotyping and genotyping methods have been used or developed for *S. aureus* including, but not limited to, ribotyping, RAPD-typing, PFGE, MLST, spa-typing, RS-PCR, coagulase gene RFLP, MLVA, micro-arrays and whole genome comparisons \[[@B7-toxins-10-00247],[@B8-toxins-10-00247],[@B9-toxins-10-00247],[@B10-toxins-10-00247],[@B11-toxins-10-00247]\]. Many molecular epidemiological studies have been based on the use of selected targets in the genome, giving rise to banding patterns based on restriction- or primer binding sites, or to allelic profiles for housekeeping or virulence genes \[[@B12-toxins-10-00247]\]. Such studies continue to be useful diagnostic tools when the aim is to understand pathogen sources and transmission mechanisms. Moreover, among the genotyping methods, the RS-PCR, based on amplifying the 16S-23S rRNA intergenic spacer region by PCR (ribosomal spacer-PCR), showed to be accurate, rapid and inexpensive with a discriminatory power like the other more-recognized genotyping methods \[[@B13-toxins-10-00247]\].

The aim of this study was to genotype by RS-PCR and compare the molecular-epidemiologic profiles of a large world collection of *S. aureus* isolates to deepen the knowledge on the circulating genetic lineages among the cow population with mastitis. The isolates were investigated for three genes related to host adhesion and invasion (*clfA*, clumping factor; *cna*, collagen-binding protein; *fmtB*, cell wall-associated protein), 22 genes that have the potential to interfere with host defence mechanisms (*tsst*, toxic shock syndrome toxin-1; *scn*, staphylococcal complement inhibitor; *chp*, chemotaxis inhibitory protein; *sak*, staphylokinase; enterotoxins from *sea* to *sel*; exfoliative toxins *eta*, *etb* and leucocidins *lukE*, *lukE-lukD*, *lukM*, *lukSF-PV*), and the gene encoding the acquisition of methicillin resistance (*mecA*).

2. Results {#sec2-toxins-10-00247}
==========

In this study, a total of 120 isolates collected from eight different countries were genotyped by RS-PCR and analyzed for 26 virulence factors related to *S. aureus* pathogenicity, such as genes related to host adhesion and invasion (*clfA*, *cna*, *fmtB*), genes that have the potential to interfere with host defense mechanisms (*tsst*, *scn*, *chp*, *sak*, enterotoxins from *sea* to *sel* and leukotoxins), and the gene encoding the acquisition of methicillin resistance (*mecA*).

2.1. RS-PCR Genotyping {#sec2dot1-toxins-10-00247}
----------------------

For the RS-PCR genotyping analysis, the genotypes, were named and extended according to a previous study \[[@B14-toxins-10-00247]\] leading to the genotypes GTA to GTZ, followed by the genotypes GTAA to GTAZ, GTBA to GTBZ, and so on. A genotypic variant, differing in only 1 band of a known genotype, was indicated with roman numerals superscripted after the name of the genotype (e.g., GTR^I^, GTR^II^). Variation in more than one band, between profiles, was regarded as a new genotype. Finally, genotypes and their variants (e.g., genotype GTB and its variants GTB^I^, GTB^II^, GTB^III^), encompassing at least 5% of all the strains, were combined into genotypic clusters (CL).

New genotypes comprising GTAR, GTBZ, and GTCA were observed for South African and Tunisian strains ([Table 1](#toxins-10-00247-t001){ref-type="table"}). For all the other countries, at maximum new variants of existing genotypes were detected. They included GTI^V^, GTI^VI^ (Argentina), GTAQ^I^, GTBN^I^, GTBN^II^, GTBY^I^ (Brazil), GTAO^I^, GTAO^II^ (Colombia), GTR^XIII^ (Italy), GTC^V^ and GTI^V^ (New York State). For each country, a specific genotypic pattern was found. Major genotypes with their variants were combined into genotypic clusters (CL) \[[@B14-toxins-10-00247]\] and showed in [Figure 1](#toxins-10-00247-f001){ref-type="fig"}. For Argentina ([Table 1](#toxins-10-00247-t001){ref-type="table"}, [Figure 1](#toxins-10-00247-f001){ref-type="fig"}) it mainly consisted of CLI (56% of GTI variants) and CLR (25% of GTR variants), whereas for Brazil CLBN (20% of GTBN plus variants) and CLBY (40% of GTBY plus a variants) were most prominent. The Colombian strains were mainly positive for GTAO and its variants (CLAO, 60%). In the case of Germany and Italy, the most prevalent genotypes were GTC^I^, GTR plus variants, and GTB, combined into CLC (30%), CLR (64.7%) and CLB (29.4%), respectively. Finally, the main genotypes observed for the South African and Tunisian strains were GTR and its variants (CLR, 45%), whereas the American strains were mainly positive for GTC and variants of it (CLC, 70.6%). In conclusion, cluster C was observed mostly in Germany and New York State, while CLR was widely disseminated in seven countries; especially it was frequently detected in Argentina, Germany, Italy, South Africa and Tunisia but less in Colombia and New York State.

All the existing genotypes including their variants such as GTC and GTC^I^ had been previously isolated from bovine intramammary infection or bovine milk. Exceptions were GTBH (sandwich with Mozzarella) and GTAO (human nasal carriage).

2.2. Virulence Genes {#sec2dot2-toxins-10-00247}
--------------------

All the 120 isolates analyzed in this study were positive for coagulase (*coa*) and thermonuclease (*nuc*) genes, but negative for a gene involved in host cell invasion, the exfoliative toxin (*etb*), and for SEB and SEE enterotoxins. The distribution of the virulence genes for each country is described in detail below.

Dendograms derived from the combination between RS-PCR profiles and the virulence factors for each country, showing the similarity among the strains, were reported as [Supplementary Figure S1](#app1-toxins-10-00247){ref-type="app"}.

### 2.2.1. Argentina {#sec2dot2dot1-toxins-10-00247}

As reported in [Table 2](#toxins-10-00247-t002){ref-type="table"}, all the 16 Argentinian isolates were positive for a leucocidin (*lukE-lukD*) and for an enterotoxin (*sei*), but negative for the gene encoding exfoliative toxin (*eta*), for *mecA*, *sel* and *sej*. All strains were also negative for two mobile genetic element genes (*chp*, *scn*), while 5 carried *sak*.

Out of 16 isolates, 15 (93.7%) had the genes encoding for *lukE* and *clfA*, 14 (87.5%) for a cell wall-associated protein (*fmtB*), 13 (81.2%) harboured the genes encoding for collagen-binding protein (*cna*), *lukM* and Panton-Valentine leucocidin *lukSF-PV*, whereas 5 (37.5%) were positive for *sak* and/or for *tsst*, respectively.

All the 16 isolates were enterotoxigenic, harbouring at least one of the genes coding for A, C, D, G and H enterotoxins genes. Three isolates from 3 different farms were positive for 5 different enterotoxins (combination of *sea*, *sec*, *seg*, *seh* and *sei* or *sea*, *sed*, *seg*, *seh* and *sei* or *sea*, *sed*, *seg*, *seh* and *sei*) while 8 isolates from 8 different farms were positive for 4 enterotoxins (combination of *sed*, *seg*, *seh* and *sei* or *sea*, *seg*, *seh*). Four isolates, collected in 4 different farms, were positive for 3 enterotoxins genes (combination of *sea*, *seg* and *sei* or *seg*, *seh* and *sei*) and 1 isolates for 2 different enterotoxins genes (*seh*, *sei*).

### 2.2.2. Brazil {#sec2dot2dot2-toxins-10-00247}

Isolates collected from Brazil were all positive for *fmtB*, *cna*, *clfA* and for the genes encoding leucocidins (*lukE*, *lukE-lukD*, *lukM*, *lukSF-PV*) ([Table 3](#toxins-10-00247-t003){ref-type="table"}). All the Brazilian isolates were negative for genes carried on mobile genetic elements and usually present in isolates involved in human infections, such as *chp*, *scn*, and *sak*. Moreover, they were negative for *tsst*, *eta*, *mecA*, and *sec*, *sed*, *sel*, *sej*. Out of 15 isolates, 5 (33.3%) were positive for *seh*, 8 (53.3%) for both *sea* and *seh*, while a single isolate (6.6%) harboured other 2 enterotoxin genes (*seg*, *sei*).

### 2.2.3. Colombia {#sec2dot2dot3-toxins-10-00247}

As shown in [Table 4](#toxins-10-00247-t004){ref-type="table"}, all the Colombian isolates were positive for *lukE-lukD* and *cna*, but negative for *chp*, *tsst*, *eta*, *mecA* and *sec*, *sel*, *sej*. Out of 15 isolates, 14 (93.4%) were positive for *clfA* and *fmtB* genes, 13 (86.7%) for *lukSF-PV*, 10 (66.7%) for *sak* and *lukM*, and 7 (46.7%) for *scn*. Fourteen (93.3%) isolates were enterotoxigenic harbouring at least one of the genes *sea*, *sed*, *seg*, *sei* or *seh*.

The most frequently detected genes were *seh* (93.3%) and *sea* (86.6%), followed by *sei* (26.6%) and *seg* (20%). One isolate harboured all the 5 enterotoxin genes (*sea*, *sed*, *seg*, *seh* and *sei*); 2 other isolates coming from 2 different farms harboured 4 enterotoxin genes (*sea*, *seg*, *seh* and *sei*) and 1 isolate 3 enterotoxin genes (*sea*, *seh* and *sei*). Finally, 9 isolates, from 6 different farms, had the combination of genes encoding for SEA and SEH.

### 2.2.4. Germany {#sec2dot2dot4-toxins-10-00247}

All the German isolates were positive for *lukE* and *cna*, but negative for the mobile genetic element genes (*chp*, *scn*, *sak*), for *eta*, *lukSF-PV* and for enterotoxin genes *sed*, *seh*, *sel*, *sej* ([Table 5](#toxins-10-00247-t005){ref-type="table"}). Out of 17 isolates, one (6%) harboured the *mecA* gene, 4 (23.5%) the *tsst*, 13 (76.5%) the *fmtB*, 15 (88.2%) the *lukM* and 16 (94.1%) both *clfA* and *lukE-lukD* genes.

Fifteen isolates out of 17 (88.2%), collected from 15 different farms, were enterotoxigenic, harbouring at least one of the genes coding for A, C, G and I enterotoxins. The most frequently detected genes were *sea* (88.2%) and *seg* (58.8%), followed by *sei* and *sec* (29.4%). Two isolates harboured all the 4 enterotoxin genes (*sea*, *sec*, *seg*, and *sei*); 3 and 8 other isolates harboured 3 (*sea*, *sec*, and *seg*) or 2 genes (combination of *sea* and *seg*, or *sea* and *sei*), respectively.

### 2.2.5. Italy {#sec2dot2dot5-toxins-10-00247}

All the Italian isolates were positive for *lukE*, *lukE-lukD*, *cna* and *fmtB*, but negative for *chp*, *eta*, *lukSF-PV* and *seh*, *sel* enterotoxin genes ([Table 6](#toxins-10-00247-t006){ref-type="table"}). Out of 17 isolates, 14 (82.3%) were positive for *clfA* and 9 (53%) had the gene encoding *lukM*. One isolate (6%) was positive for both *scn* and *sak* genes, and other two different isolates were positive for *tsst* (6%) and *mecA* (6%), respectively.

Fourteen isolates out of 17 (82.3%) were enterotoxigenic, harbouring at least 1 of the genes coding for A, C, D, G, I and J enterotoxins. The most frequently detected genes were *sed* (82.3%) and *seg* (70.5%), followed by *sej* (64.7%), *sea* (58.8%) and *sei* (47%). Six isolates harboured 5 enterotoxin genes (combination of *sea*, *sed*, *seg*, *sei* and *sej,* or *sea*, *sed*, *seg*, *sec* and *sej*); 4 other isolates harboured 4 enterotoxin genes (combination of *sea, sei, sed* and *seg*, or *sei, sed*, *seg* and *sej* or *sea, sed*, *sej* and *seg*). Moreover, 2 isolates harboured 3 different enterotoxins (*sea*, *sed* and *seg*) and 2 isolates, from the same farm, a combination of *sed* and *sej*.

### 2.2.6. New York State {#sec2dot2dot6-toxins-10-00247}

As reported in [Table 7](#toxins-10-00247-t007){ref-type="table"}, all the New York State isolates were positive for *lukE-lukD*, but negative for *chp*, *scn*, *sak, tsst*, *eta*, *mecA* and *sec*, *sel*, *seh*, *sej*. Out of 17 isolates, 15 (88.2%) were positive for *cna* and *lukE*, while 13 (76.4%) and 9 (53%) were positive for *lukM* and *clfA* genes, respectively. In addition, 6 isolates (35.2%) and 2 (12%) had the *fmtB* and *lukSF-PV* genes, respectively. Only one isolate was not enterotoxigenic; the remaining 16 isolates (95%) harboured at least one of the genes encoding SEA, SED, SEG, SEI enterotoxins. Five isolates, collected from 5 different farms, had all the enterotoxin genes (*sea*, *sed*, *seg*, *sei*); 6 isolates, from 6 different farms, harboured 3 genes (combination of *sea*, *sed* and *seg* or *sea*, *seg* and *sei* or *sed*, *seg* and *sei*). Five isolates, from 4 different farms, had 2 enterotoxin genes (combination of *sed* and *seg* or *seg* and *sei* or *sed* and *sei*).

### 2.2.7. South Africa {#sec2dot2dot7-toxins-10-00247}

As reported in [Table 8](#toxins-10-00247-t008){ref-type="table"}, all the South African isolates were positive for *sak*, *cna*, *lukE-lukD*, *lukE* genes. All the isolates were negative for *chp*, *mecA*, *tsst* and for *sec*, *sed*, *seg*, *sej* and *sel*. In addition, 10 (90.9%) out of 11 isolates were positive for *fmtB*, 7 (63.7%) for *clfA*, 3 (27.3%) for *lukSF-PV*, 2 (18.2%) for *lukM* and 1 (9%) for *eta* genes, respectively. Ten isolates, recovered in 9 different farms, were enterotoxigenic and positive for both *sea* and *seh* genes; out of them, 3 isolates from 2 different farms, harboured also the *sei* gene.

### 2.2.8. Tunisia {#sec2dot2dot8-toxins-10-00247}

The Tunisian isolates were all positive for *fmtB*, *cna* and *clfA* genes, but negative for *eta*, *mecA*, *lukSF-PV* and *sea*, *sed*, *seg*, *sei*, *sej* ([Table 9](#toxins-10-00247-t009){ref-type="table"}). Out of 12 isolates, 11 (91.6%) harboured leucocidin genes (*lukM*, *lukE*, *lukE-lukD*). Six isolates (50%) were positive for at least one gene of the immune evasion cluster with the combination of *chp*, *scn* and *sak* for 2 isolates, *scn* and *sak* or *chp* and *scn*, respectively, while the remaining 2 isolates harboured only the *chp* gene. Moreover, 4 isolates from 4 different farms, were enterotoxigenic harbouring *sec* and *sel* (2 isolates) or *seh* genes (2 isolates).

3. Discussion {#sec3-toxins-10-00247}
=============

Pathogenic factors of *S. aureus* enable this bacterium to attach, colonize, invade and infect the host tissue. In this study, *S. aureus* isolates, collected from eight different countries, were investigated using RS-PCR genotyping and PCR analysis for the carriage of different virulence factors to examine the epidemiology of this microorganism.

The samples were obtained from collections of the collaborators, allowing a first overview about the presence of the various staphylococcal subtypes among countries. Three new genotypes were observed for South Africa whereas new variants were found in Argentina, Brazil, Colombia, Italy and New York State. As previously described \[[@B14-toxins-10-00247]\], GTB was observed only in Europe (Italy) while CLR and CLC clusters were observed throughout America, Europe and Africa; particularly CLR, which forms a large cluster containing 13 variants, was detected in each country involved, except for Brazil. It is quite well demonstrated \[[@B14-toxins-10-00247]\] that *S. aureus* CLC and CLR clusters are "dairy cattle specific" whose spreading process must have been started a long time ago, with the spreading of breeding cattle from Europe to the other countries. On the contrary, GTB derives from a more recent bovine adaptation due to a new human-to-cow host jump \[[@B13-toxins-10-00247]\]. Certainly, further studies will be necessary to explain the different geographic distribution especially for the minor genotypes.

As previously described \[[@B15-toxins-10-00247]\], *S. aureus* isolates harbouring genes coding for clumping factor (*clfA*), a cell wall-associated protein (*fmtB*), and collagen-binding protein (*cna*) have a greater capability to adhere to extracellular matrix proteins, essential for colonization and the establishment of infections. Our results indicated that, except for the American isolates with a lower presence of *fmtB* and *clfA* genes, in the other seven countries these genes were widely present in the circulating isolates particularly in Brazilian and Tunisian ones. The presence of these genes, necessary for host invasion, could improve the persistence of the microorganism in the host, ensuring the probability of survival in the population.

And more, according to previous studies \[[@B11-toxins-10-00247],[@B13-toxins-10-00247],[@B15-toxins-10-00247]\], except for Brazil, Germany and USA, the remaining countries showed isolates encoding at least 2 virulence factors out of staphylococcal complement inhibitor (*scn*), chemotaxis inhibitory protein of *S. aureus* (*chp*) and staphylokinase (*sak*). These virulence factors show activity prevalently against the human innate immune system but their presence among isolates recovered in herds with high prevalence of *S. aureus* mastitis suggests their involvement also in bovine mammary gland immune response \[[@B16-toxins-10-00247]\], and should be further studied, especially in Colombia and Tunisia where this gene cluster is quite common \[[@B17-toxins-10-00247]\]. In a previous study \[[@B4-toxins-10-00247]\], human strains were grouped in 7 immune evasion cluster (IEC) types, depending on the presence of 2 out of the 3 genes, in association or not with *sea* or *sep*. Unlike Colombian, Italian, South African strains and Tunisian isolates, the Argentinian ones carried only one gene, *sak*, showing a clear distance from human strains. Among the isolates from the other countries, uniquely the Tunisian strains testing positive for IEC, did not harbor *sea*.

Superantigens, especially enterotoxins, have been suggested to play a role in the development of mastitis, for instance by creating an attractive environment for colonization \[[@B18-toxins-10-00247]\] since they are more often identified in *S. aureus* isolated from cows with mastitis than in isolates from healthy cows or from the environment \[[@B19-toxins-10-00247]\]. As a result, enterotoxins support the pathogenesis of *S. aureus* compromising mammary gland immune response and susceptibility to antibiotics resulting in the onset of many diseases \[[@B20-toxins-10-00247]\]. In this study, *sea* and *sei* were the main enterotoxin genes present in all countries except for Tunisia (prevalence between 50% and 90%). While *seh* gene had a frequency higher than 90% in Argentinian, Brazilian, Colombian and South African isolates, *sej* and *sel* genes were carried only by Italian and Tunisian isolates, respectively. Among the 120 isolates analyzed, only 17 (14%) were not enterotoxigenic (1 from Argentina, 1 from Colombia, 2 isolates from Germany, 3 from Italy, 1 from New York State, 1 from South Africa, and 8 from Tunisia). The remaining 103 isolates (86%) harboured a combination of at least 2 up to 5 enterotoxins with the linkages between *sea*, *sed*, *seg* and *seh* confirming their predominance in cows, as previously described \[[@B21-toxins-10-00247],[@B22-toxins-10-00247],[@B23-toxins-10-00247],[@B24-toxins-10-00247]\]. The absence of the enterotoxin genes *seb* and *see* in our isolates was in accordance with previous results \[[@B15-toxins-10-00247],[@B22-toxins-10-00247],[@B25-toxins-10-00247],[@B26-toxins-10-00247]\].

Here, among all the isolates we did not find the presence of *etb* exfoliative gene and only one isolate from South Africa was positive for *eta* gene. These results agree with previous studies conducted in different countries \[[@B27-toxins-10-00247],[@B28-toxins-10-00247],[@B29-toxins-10-00247]\], showing that *S. aureus* isolates from animals with mastitis were rarely positive for exfoliative toxins. On the contrary, in Europe, Kot and coworkers reported a 14.5% of *S. aureus* harbouring the *eta* gene from bovine mastitis \[[@B30-toxins-10-00247]\]. In our study, the presence of *tsst* gene was more relevant, being carried by 37% of Argentinian, 23% of German, 16% of Tunisian and 6% of Italian isolates. All these isolates were also positive at least for a combination of *sec* and *sel*, or *sec*, *seg*, and *sei* or *sec*, *seg* and *sej* or *sec*, *seg* and *sel* genes which are located on the same bovine staphylococcal pathogenicity island (SaPIbov), confirming a positive correlation between *sec, sei* or *sej* and *tsst*, as previously reported \[[@B31-toxins-10-00247]\].

Panton-Valentine leucocidin, encoded by 2 co-transcribed genes located on a prophage, causes leukocyte destruction and tissue necrosis \[[@B32-toxins-10-00247]\]. The presence of PVL-encoding genes in *S. aureus* is reported to be associated with increased disease severity \[[@B33-toxins-10-00247]\]. In the present study, the presence of PVL gene was lower than 20% in South Africa and New York State, higher than 80% in Argentina, Colombia and Brazil, while in Germany, Italy and Tunisia none of the *S. aureus* isolates carried the gene. For European countries, previously published results were in accordance with this study \[[@B34-toxins-10-00247],[@B35-toxins-10-00247]\]. Additionally, genes encoding the bicomponent leucotoxin *lukE-lukD* were observed in all isolates, and, except for South Africa with only 2 isolates, most of the other isolates harboured *lukM*, a gene encoding one operon like the one of PVL. The high rates of *lukE-lukD* and *lukM* found in this study agree with other reports \[[@B34-toxins-10-00247],[@B35-toxins-10-00247],[@B36-toxins-10-00247]\]. Additionally, only 2 isolates, one from Germany and one from Italy were positive for *mec*A, confirming the low diffusion of MRSA among bovine mastitis isolates \[[@B37-toxins-10-00247],[@B38-toxins-10-00247]\]; interestingly, they are both GTS, in accordance with previous results \[[@B13-toxins-10-00247]\].

4. Conclusions {#sec4-toxins-10-00247}
==============

Knowledge about the epidemiology of *S. aureus* genotypes in dairy species and herds might help to formulate strategies for reducing the infection spreading and for focused treatments. In our work we found that CLR and CLC clusters and some virulence factors related to host invasion, such as *fmtB*, *cna*, *clfA* or immune defense impairment such as leukocidin genes, were the most frequent ones. These genes combination could be related to the *S. aureus* ability to colonize the host. Further, *fmtB* gene has been shown to be related to the resistance of *S. aureus* to β-lactam antibiotics \[[@B10-toxins-10-00247]\]. Therefore, due to the prevalence of these genes worldwide, it might be useful screening them in *S. aureus* isolates to help predicting clinical outcomes and specially to identify harmful strains. Meanwhile, our work demonstrated also that each country had a specific genotypic pattern and in some countries the isolates harboured some virulence factors, such as PVL-encoding genes, with high prevalence, recommending a close surveillance of *S. aureus* isolates in the animals of these countries to avoid the wide spreading of these genes. Finally, it is notable that most of the isolates worldwide were negative for *mecA*, confirming the evidence of the low diffusion of MRSA among bovine mastitis isolates, as previously described \[[@B37-toxins-10-00247],[@B38-toxins-10-00247]\].

In conclusion, this study confirms the wide variety of *S. aureus* genotypes found in dairy cattle worldwide and that genetic differences are related to geographical origin of the isolates, suggesting that considering the region of interest and the strain virulence might help to formulate strategies directed to reduce the infection spreading and to set up control measures according to pathogen and host features. Therefore, based the characterization of the circulating strain, the farmer would be able to decide to segregate positive cows applying hygienic milking procedures and a suitable milking order, or even to cull the infected animals.

5. Materials and Methods {#sec5-toxins-10-00247}
========================

5.1. Sample Collection and Bacteriological Analysis {#sec5dot1-toxins-10-00247}
---------------------------------------------------

A total of 120 *S. aureus* isolates from eight countries Argentina, Brazil, Colombia, Germany, Italy, New York State, South Africa, Tunisia, ([Figure 1](#toxins-10-00247-f001){ref-type="fig"}), were selected for this study ([Table 10](#toxins-10-00247-t010){ref-type="table"}). Isolates of *S. aureus* were taken from the authors' bacterial culture collections (BC) and they included isolates previously collected (Argentina: from April 2015 to June 2017; Brazil: from July 2014 to May 2015; Colombia: from November 2016 to March 2017; Germany: from May 2012 to August 2016; Italy: from September 2012 to December 2016; New York State: from January 2017 to April 2017; South Africa: from August 2016 to February 2017; Tunisia: from September 2015 to December 2016) from clinical mastitis and from high somatic cell count (**H**) samples. The milk collection was made from quarters (**Q**) or composite milk samples (**C**). The isolates were stored at −20 °C until they were transported to the Italian laboratory (University of Milan) where storage was continued at −20 °C until further use. During transport to the laboratory, they were kept frozen using styrofoam boxes and dry ice (for long distances) or wet ice (for short distances).

After samples thawing, 10 μL were streaked on blood agar plate. The plates were then incubated aerobically at 37 °C and examined after 24 h. The colonies were provisionally identified based on morphology and hemolysis patterns and confirmed by coagulase test.

5.2. DNA Extraction {#sec5dot2-toxins-10-00247}
-------------------

DNA was extracted from isolates using the protocol previously described by Cremonesi and co-workers \[[@B39-toxins-10-00247]\]. The amount and quality of DNA were measured using a NanoDrop ND-1000 spectrophotometer (Nano-Drop Technologies, Wilmington, DE, USA), and DNA was stored at −20 °C until use.

5.3. Genotyping {#sec5dot3-toxins-10-00247}
---------------

All the 120 *nuc* positive isolates (=*S. aureus*) were then genotyped by RS-PCR and a miniaturized electrophoresis system (Agilent Technologies, Santa Clara, CA, USA) as previously described \[[@B22-toxins-10-00247],[@B40-toxins-10-00247]\] where a detailed working protocol is given. The method is based on amplification of the 16S--23S rRNA intergenic spacer region. Each reaction contained (total volume 25 μL) 1× HotStarTaq Master Mix (Qiagen, Hilden Germany), 800 nM of each primer (G1 and L1 primer) \[[@B22-toxins-10-00247]\] and 7 μL of DNA (originally extracted DNA diluted 1:100 in water). The PCR profile was: 95 °C for 15 min, followed by 27 cycles comprising 94 °C for 1 min, followed by a 2 min ramp and annealing at 55 °C for 7 min. After a further 2 min ramp, extension was done at 72 °C for 2 min. PCR was terminated by incubating at 72 °C for 10 min followed by cooling down to 4 °C. One μL of each of the PCR products was then used for the miniaturized electrophoresis (Agilent) performed as described by the manufacturer of the system. New genotypes were named and extended according to Fournier and co-workers \[[@B22-toxins-10-00247]\] leading to the genotypes GTA to GTZ, followed by the genotypes GTAA to GTAZ, GTBA to GTBZ, and GTCA. An electrophoretic pattern differing in one band from the one of a known genotype was considered as a genotypic variant. It was indicated with roman numerals superscripted after the name of the genotype (e.g., GTR^I^, GTR^II^). To identify the genotypes and their variants of the present strains, a freely available, in-house computer program, calculating the corresponding Mahalanobis distance of informative peak sizes and by comparing it to those of the prototype strains using the "Mahalanobis Distances of Staph. aureus Genotypes" software \[[@B41-toxins-10-00247]\]. Finally, genotypes and their variants were combined into genotypic clusters (CL) \[[@B14-toxins-10-00247]\].

5.4. Molecular Isolates Characterization {#sec5dot4-toxins-10-00247}
----------------------------------------

The DNA was amplified to investigate the presence of 26 factors that can contribute in different ways to *S. aureus* pathogenicity and therefore influence the management of the disease. In this study genes encoding enterotoxins (from *sea* to *sel*), leucocidins (*lukE*, *lukSF*-*PV*, *lukE*-*lukD*, *lukM*), the acquisition of methicillin resistance (*mecA*) and genes related to host invasion (*clfA*, *fmtB*, *cna, eta*, *etb*) or to factors that have the potential to interfere with host defense mechanisms (*tsst*, *scn*, *chp*, *sak*) were analyzed using primers and protocols described in literature and listed in [Table 11](#toxins-10-00247-t011){ref-type="table"}. The amplified PCR fragments were visualized on 2% agarose gel electrophoresis (GellyPhor, Euroclone, Milan, Italy), stained with ethidium bromide (0.05 mg/mL; Sigma Aldrich, Milan, Italy), and visualized by UV transilluminator (BioView Ltd., Nes Ziona, Israel). A 100 bp DNA ladder (Finnzymes, Espoo, Finland) was included in each gel.

Grouping of the RS-PCR profiles and the virulence factors was obtained with the BioNumeric 5.0 software package (Applied Maths, Kortrjik, Belgium) using the UPGMA (unweighted pair group method using arithmetic averages) cluster analysis.

The authors acknowledge Filippo Biscarini (IBBA-CNR) and Stefano Morandi (ISPA-CNR) for their valuable help in genotypic cluster circular representation and for dendogram analysis, respectively.

The following are available online at <http://www.mdpi.com/2072-6651/10/6/247/s1>, Figure S1: Unweighted pair-group method with arithmetic averages (UPGMA)-based dendrogram derived from the combined RS-PCR profiles and the virulence factors of the *S. aureus* strains considered in this study.

###### 

Click here for additional data file.
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![Representation of the major genotypes with their variants combined into genotypic clusters (CL).](toxins-10-00247-g001){#toxins-10-00247-f001}

toxins-10-00247-t001_Table 1

###### 

Distribution of genotypes in the eight countries.

  Country          Genotypic Cluster (CL)   Genotype (Isolate No.)                   New Genotypes or Variants             Total Strains
  ---------------- ------------------------ ---------------------------------------- ------------------------------------- ---------------
                   CLC                      GTC (6, 15)                                                                    
                   CLI                      GTI^I^ (1, 4, 5, 7)                                                            
                                            GTI^II^ (10, 11, 14)                                                           
                                            GTI^V^ (9)                                                                     
  Argentina                                 GTI^VI^ (12)                             GTI^V^, GTI^VI^                       16
                   CLP                      GTP (8)                                                                        
                   CLR                      GTR^I^ (2, 3, 16)                                                              
                                            GTR^VI^ (13)                                                                   
                   CLAQ                     GTAQ (31)                                                                      
                                            GTAQ^I^ (30)                                                                   
                   CLBA                     GTBA (17)                                                                      
                   CLBN                     GTBN (29)                                                                      
                                            GTBN^I^ (20)                                                                   
                                            GTBN^II^ (23)                                                                  
  Brasil           CLBY                     GTBY (18, 19, 21, 28)                    GTBN^I^, GTBN^II^, GTBY^I^, GTAQ^I^   15
                                            GTBY^I^ (24, 25)                                                               
                   CLC                      GTC^III^ (26)                                                                  
                   CLS                      GTS^I^ (22)                                                                    
                   CLZ                      GTZ (27)                                                                       
                   CLA                      GTA^I^ (33)                                                                    
                   CLAO                     GTAO (39, 40, 41)                                                              
                                            GTAO^I^ (38, 43, 44, 46)                                                       
  Colombia                                  GTAO^II^ (32, 42)                        GTAO^I^, GTAO^II^                     15
                   CLBY                     GTBY (45)                                                                      
                   CLI                      GTI^I^ (35, 36, 37)                                                            
                   CLR                      GTR (34)                                                                       
                   CLC                      GTC^I^ (54, 55, 56, 57, 59)                                                    
                   CLR                      GTR (47, 48, 49, 51)                                                           
  Germany                                   GTR^I^ (58, 60, 61, 63)                                                        17
                                            GTR^II^ (50, 62)                                                               
                                            GTR^VI^ (52)                                                                   
                   CLS                      GTS (53)                                                                       
                   CLB                      GTB (64, 65, 66, 78, 80)                                                       
                   CLBG                     GTBG (70)                                                                      
                   CLBQ                     GTBQ^I^ (73, 79)                                                               
                   CLC                      GTC^I^ (69, 75)                                                                
  Italy                                     GTC^II^ (76)                             GTR^XIII^                             17
                   CLR                      GTR^I^ (67, 68)                                                                
                                            GTR^XIII^ (72)                                                                 
                                            GTR^VI^ (71)                                                                   
                   CLS                      GTS (77)                                                                       
                   CLZ                      GTZ (74)                                                                       
                   CLAI                     GTAI (93)                                                                      
                   CLC                      GTC (82, 83, 85, 86, 88, 94, 96)                                               
                                            GTC^I^ (81, 87, 91)                                                            
  New York State                            GTC^III^ (90)                            GTC^V^, GTI^V^                        17
                                            GTC^V^ (95)                                                                    
                   CLI                      GTI^I^ (89)                                                                    
                                            GTI^V^ (92, 97)                                                                
                   CLR                      GTR^I^ (84)                                                                    
                   CLAR                     GTAR (101)                                                                     
                   CLBH                     GTBH (98)                                                                      
  South Africa     CLBZ                     GTBZ (99, 100, 105)                      GTAR, GTBZ, GTCA                      11
                   CLCA                     GTCA (103)                                                                     
                   CLR                      GTR (102, 104, 107, 108)                                                       
                                            GTR^VI^ (106)                                                                  
                   CLAJ                     GTAJ (111)                                                                     
                   CLBW                     GTBW^II^ (110)                                                                 
  Tunisia          CLCA                     GTCA (113, 114)                          GTCA                                  12
                   CLCB                     GTCB (119)                                                                     
                   CLR                      GTR^I^ (109)                                                                   
                                            GTR^VI^ (112, 115, 116, 117, 118, 120)                                         

toxins-10-00247-t002_Table 2

###### 

Molecular characteristics of strains isolated in Argentina.

  Isolates   RS-PCR       *clfA*   *fmtB*   *cna*   *lukE*   *lukM*   *lukE-lukD*   *lukSF-PV*   *scn*   *chp*   *sak*   *eta*   *tsst*   Enterotoxins Positive       *mecA*
  ---------- ------------ -------- -------- ------- -------- -------- ------------- ------------ ------- ------- ------- ------- -------- --------------------------- --------
  1          GTI^I^       \+       \+       \+      \+       \-       \+            \+           \-      \-      \-      \-      \+       *sea, seg, sei*             \-
  2          GTR^I^       \+       \+       \+      \+       \+       \+            \+           \-      \-      \+      \-      \-       *sed, seg, seh, sei*        \-
  3          GTR^I^       \+       \-       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       *sed, seg, seh, sei*        \-
  4          GTI^I^       \-       \-       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       *sea, seg, sei*             \-
  5          GTI^I^       \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       *sed, seg, seh, sei*        \-
  6          GTC          \+       \+       \+      \+       \+       \+            \-           \-      \-      \+      \-      \+       *sea, sec, seg, seh, sei*   \-
  7          GTI^I^       \+       \+       \+      \+       \+       \+            \-           \-      \-      \+      \-      \+       *sea, seg, seh, sei*        \-
  8          GTP          \+       \+       \+      \-       \+       \+            \+           \-      \-      \+      \-      \-       *sea, sed, seg, seh, sei*   \-
  9          GTI^V^ \*    \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       *sed, seg, seh, sei*        \-
  10         GTI^II^      \+       \+       \-      \+       \+       \+            \+           \-      \-      \+      \-      \-       *sea, seg, seh, sei*        \-
  11         GTI^II^      \+       \+       \-      \+       \-       \+            \+           \-      \-      \-      \-      \-       *sea, seg, seh, sei*        \-
  12         GTI^VI^ \*   \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \+       *seg, seh, sei*             \-
  13         GTR^VI^ \*   \+       \+       \-      \+       \+       \+            \+           \-      \-      \-      \-      \-       *seg, seh, sei*             \-
  14         GTI^II^      \+       \+       \+      \+       \-       \+            \+           \-      \-      \-      \-      \-       *sea, sed, seg, seh, sei*   \-
  15         GTC          \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \+       *sea, seg, seh, sei*        \-
  16         GTR^I^       \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *seh, sei*                  \-

\* new genotypes or new variants.

toxins-10-00247-t003_Table 3

###### 

Molecular characteristics of strains isolated in Brazil.

  Isolates   RS-PCR       *clfA*   *fmtB*   *cna*   *lukE*   *lukM*   *lukE-lukD*   *lukSF-PV*   *scn*   *chp*   *sak*   *eta*   *tsst*   Enterotoxins Positive   *mecA*
  ---------- ------------ -------- -------- ------- -------- -------- ------------- ------------ ------- ------- ------- ------- -------- ----------------------- --------
  17         GTBA         \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       *sea, seh*              \-
  18         GTBY         \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       *sea, seh*              \-
  19         GTBY         \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       *seh*                   \-
  20         GTBN^I^ \*   \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       *seh*                   \-
  21         GTBY         \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       *seh*                   \-
  22         GTS^I^       \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       *seh*                   \-
  23         GTBN^II^     \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       *seh*                   \-
  24         GTBY^I^      \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       *sea, seh*              \-
  25         GTBY^I^      \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       *sea, seh*              \-
  26         GTC^III^     \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       *sea, seh*              \-
  27         GTZ          \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       *sea, seg, seh, sei*    \-
  28         GTBY         \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       \-                      \-
  29         GTBN         \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       \-                      \-
  30         GTAQ^I^      \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       *sea, seh*              \-
  31         GTAQ         \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       *sea, seh*              \-

\* new genotypes or new variants.

toxins-10-00247-t004_Table 4

###### 

Molecular characteristics of strains isolated in Colombia.

  Isolates   RS-PCR        *clfA*   *fmtB*   *cna*   *lukE*   *lukM*   *lukE-lukD*   *lukSF-PV*   *scn*   *chp*   *sak*   *eta*   *tsst*   Enterotoxins Positive       *mecA*
  ---------- ------------- -------- -------- ------- -------- -------- ------------- ------------ ------- ------- ------- ------- -------- --------------------------- --------
  32         GTAO^II^ \*   \-       \+       \+      \+       \-       \+            \+           \-      \-      \-      \-      \-       \-                          \-
  33         GTA^I^        \+       \+       \+      \+       \+       \+            \+           \+      \-      \+      \-      \-       *sea, seh*                  \-
  34         GTR           \+       \+       \+      \+       \+       \+            \+           \+      \-      \+      \-      \-       *seh*                       \-
  35         GTI^I^        \+       \+       \+      \+       \+       \+            \+           \+      \-      \+      \-      \-       *sea, seh*                  \-
  36         GTI^I^        \+       \+       \+      \+       \-       \+            \-           \+      \-      \+      \-      \-       *sea, seh*                  \-
  37         GTI^I^        \+       \+       \+      \+       \+       \+            \-           \+      \-      \+      \-      \-       *sea, seh*                  \-
  38         GTAO^I^ \*    \+       \+       \+      \+       \+       \+            \+           \+      \-      \+      \-      \-       *sea, seh*                  \-
  39         GTAO          \+       \+       \+      \+       \+       \+            \+           \-      \-      \+      \-      \-       *sea, seh*                  \-
  40         GTAO          \+       \+       \+      \+       \+       \+            \+           \-      \-      \+      \-      \-       *sea, seh*                  \-
  41         GTAO          \+       \-       \+      \+       \-       \+            \+           \+      \-      \+      \-      \-       *sea, seh*                  \-
  42         GTAO^II^ \*   \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       *sea, sed, seg, seh, sei*   \-
  43         GTAO^I^ \*    \+       \+       \+      \+       \+       \+            \+           \-      \-      \+      \-      \-       *sea, seg, seh, sei*        \-
  44         GTAO^I^ \*    \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       *sea, seg, seh, sei*        \-
  45         GTBY          \+       \+       \+      \-       \-       \+            \+           \-      \-      \-      \-      \-       *sea, seh*                  \-
  46         GTAO^I^ \*    \+       \+       \+      \+       \+       \+            \+           \-      \-      \-      \-      \-       *sea, seh, sei*             \-

\* new genotypes or new variants.

toxins-10-00247-t005_Table 5

###### 

Molecular characteristics of strains isolated in Germany.

  Isolates   RS-PCR    *clfA*   *fmtB*   *cna*   *lukE*   *lukM*   *lukE-lukD*   *lukSF-PV*   *scn*   *sak*   *chp*   *eta*   *tsst*   Enterotoxins Positive   *mecA*
  ---------- --------- -------- -------- ------- -------- -------- ------------- ------------ ------- ------- ------- ------- -------- ----------------------- --------
  47         GTR       \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea*                   \-
  48         GTR       \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea*                   \-
  49         GTR       \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea, seg*              \-
  50         GTR^II^   \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea, seg*              \-
  51         GTR       \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea, seg*              \-
  52         GTR^VI^   \+       \+       \+      \+       \-       \+            \-           \-      \-      \-      \-      \-       \-                      \-
  53         GTS       \-       \+       \+      \+       \-       \-            \-           \-      \-      \-      \-      \-       \-                      \+
  54         GTC^I^    \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea, sec, seg, sei*    \-
  55         GTC^I^    \+       \-       \+      \+       \+       \+            \-           \-      \-      \-      \-      \+       *sea, sec, seg*         \-
  56         GTC^I^    \+       \-       \+      \+       \+       \+            \-           \-      \-      \-      \-      \+       *sea, sec, seg*         \-
  57         GTC^I^    \+       \-       \+      \+       \+       \+            \-           \-      \-      \-      \-      \+       *sea, sec, seg, sei*    \-
  58         GTR^I^    \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea, sei*              \-
  59         GTC^I^    \+       \-       \+      \+       \+       \+            \-           \-      \-      \-      \-      \+       *sea, sec, seg*         \-
  60         GTR^I^    \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea, seg*              \-
  61         GTR^I^    \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea, seg*              \-
  62         GTR^II^   \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea, sei*              \-
  63         GTR^I^    \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea, sei*              \-

toxins-10-00247-t006_Table 6

###### 

Molecular characteristics of strains isolated in Italy.

  Isolates   RS-PCR         *clfA*   *fmtB*   *cna*   *lukE*   *lukM*   *lukE-lukD*   *lukSF-PV*   *scn*   *chp*   *sak*   *eta*   *tsst*   Enterotoxins Positive       *mecA*
  ---------- -------------- -------- -------- ------- -------- -------- ------------- ------------ ------- ------- ------- ------- -------- --------------------------- --------
  64         GTB            \+       \+       \+      \+       \-       \+            \-           \-      \-      \-      \-      \-       \-                          \-
  65         GTB            \+       \+       \+      \+       \-       \+            \-           \-      \-      \-      \-      \-       *sed, sej*                  \-
  66         GTB            \-       \+       \+      \+       \-       \+            \-           \-      \-      \-      \-      \-       *sed, sej*                  \-
  67         GTR^I^         \+       \+       \+      \+       \-       \+            \-           \-      \-      \-      \-      \-       \-                          \-
  68         GTR^I^         \+       \+       \+      \+       \-       \+            \-           \-      \-      \-      \-      \-       \-                          \-
  69         GTC^I^         \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sed, seg, sei, sej*        \-
  70         GTBG           \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sed, seg, sei, sej*        \-
  71         GTR^VI^        \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea, sed, seg, sei, sej*   \-
  72         GTR^XIII^ \*   \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea, sed, seg, sei*        \-
  73         GTBQ^I^        \+       \+       \+      \+       \-       \+            \-           \-      \-      \-      \-      \-       *sea, sed, seg, sei, sej*   \-
  74         GTZ            \+       \+       \+      \+       \-       \+            \-           \-      \-      \-      \-      \-       *sea, sed, seg, sei, sej*   \-
  75         GTC^I^         \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea, sed, seg*             \-
  76         GTC^II^        \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \+       *sea, sec, sed, seg, sej*   \-
  77         GTS            \-       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea, sed, seg*             \+
  78         GTB            \+       \+       \+      \+       \+       \+            \-           \+      \-      \+      \-      \-       *sea, sed, seg, sei, sej*   \-
  79         GTBQ^I^        \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea, sed, seg, sej*        \-
  80         GTB            \-       \+       \+      \+       \-       \+            \-           \-      \-      \-      \-      \-       *sea, sed, seg, sei, sej*   \-

\* new genotypes or new variants.

toxins-10-00247-t007_Table 7

###### 

Molecular characteristics of strains isolated in New York State.

  Isolates   RS-PCR      *clfA*   *fmtB*   *cna*   *lukE*   *lukM*   *lukE-lukD*   *lukSF-PV*   *scn*   *chp*   *sak*   *eta*   *tsst*   Enterotoxins Positive   *mecA*
  ---------- ----------- -------- -------- ------- -------- -------- ------------- ------------ ------- ------- ------- ------- -------- ----------------------- --------
  81         GTC^I^      \+       \-       \+      \+       \-       \+            \-           \-      \-      \-      \-      \-       *sea, sed, seg, sei*    \-
  82         GTC         \-       \-       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea, sed, seg, sei*    \-
  83         GTC         \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sed, seg*              \-
  84         GTR^I^      \+       \+       \+      \+       \-       \+            \-           \-      \-      \-      \-      \-       *sed, seg*              \-
  85         GTC         \+       \-       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sed, seg, sei*         \-
  86         GTC         \+       \-       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *seg, sei*              \-
  87         GTC^I^      \+       \-       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea, sed, seg*         \-
  88         GTC         \+       \-       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea, sed, seg, sei*    \-
  89         GTI^I^      \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sed, seg, sei*         \-
  90         GTC^III^    \-       \-       \-      \-       \+       \+            \-           \-      \-      \-      \-      \-       *sea, sed, seg*         \-
  91         GTC^I^      \-       \-       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea, sed, seg, sei*    \-
  92         GTI^V^ \*   \-       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sed, sei*              \-
  93         GTA^I^      \+       \-       \+      \-       \-       \+            \-           \-      \-      \-      \-      \-       *sea, sed, seg, sei*    \-
  94         GTC         \-       \-       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *sea, seg, sei*         \-
  95         GTC^V^ \*   \-       \-       \-      \+       \+       \+            \+           \-      \-      \-      \-      \-       *sea, seg, sei*         \-
  96         GTC         \-       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       *seg, sei*              \-
  97         GTI^V^ \*   \-       \+       \+      \+       \-       \+            \+           \-      \-      \-      \-      \-       \-                      \-

\* new genotypes or new variants.

toxins-10-00247-t008_Table 8

###### 

Molecular characteristics of strains isolated in South Africa.

  Isolates   RS-PCR    *clfA*   *fmtB*   *cna*   *lukE*   *lukM*   *lukE-lukD*   *lukSF-PV*   *scn*   *chp*   *sak*   *eta*   *tsst*   Enterotoxins Positive   *mecA*
  ---------- --------- -------- -------- ------- -------- -------- ------------- ------------ ------- ------- ------- ------- -------- ----------------------- --------
  98         GTBH      \+       \+       \+      \+       \-       \+            \+           \-      \-      \+      \-      \-       *sea, seh*              \-
  99         GTBZ \*   \-       \+       \+      \+       \-       \+            \-           \-      \-      \+      \-      \-       *sea, seh, sei*         \-
  100        GTBZ \*   \-       \+       \+      \+       \-       \+            \-           \-      \-      \+      \-      \-       *sea, seh, sei*         \-
  101        GTAR \*   \-       \+       \+      \+       \-       \+            \-           \-      \-      \+      \-      \-       *sea, seh, sei*         \-
  102        GTR       \+       \+       \+      \+       \+       \+            \-           \-      \-      \+      \-      \-       *sea, seh*              \-
  103        GTCA \*   \+       \+       \+      \+       \-       \+            \-           \+      \-      \+      \+      \-       *sea, seh*              \-
  104        GTR       \+       \+       \+      \+       \-       \+            \-           \-      \-      \+      \-      \-       *sea, seh*              \-
  105        GTBZ \*   \-       \-       \+      \+       \-       \+            \-           \-      \-      \+      \-      \-       *sea, seh*              \-
  106        GTR^VI^   \+       \+       \+      \+       \+       \+            \-           \-      \-      \+      \-      \-       *sea, seh*              \-
  107        GTR       \+       \+       \+      \+       \-       \+            \+           \-      \-      \+      \-      \-       *sea, seh*              \-
  108        GTR       \+       \+       \+      \+       \-       \+            \+           \-      \-      \+      \-      \-       \-                      \-

\* new genotypes or new variants.

toxins-10-00247-t009_Table 9

###### 

Molecular characteristics of strains isolated in Tunisia.

  Isolates   RS-PCR     *clfA*   *fmtB*   *cna*   *lukE*   *lukM*   *lukE-lukD*   *lukSF-PV*   *scn*   *chp*   *sak*   *eta*   *tsst*   Enterotoxins Positive   *mecA*
  ---------- ---------- -------- -------- ------- -------- -------- ------------- ------------ ------- ------- ------- ------- -------- ----------------------- --------
  109        GTR^I^     \+       \+       \+      \-       \-       \+            \-           \-      \-      \-      \-      \-       \-                      \-
  110        GTBW^II^   \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \+       *sec, sel*              \-
  111        GTAJ       \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \+       *sec, sel*              \-
  112        GTR^VI^    \+       \+       \+      \+       \+       \+            \-           \+      \+      \+      \-      \-       \-                      \-
  113        GTCA       \+       \+       \+      \+       \+       \+            \-           \-      \+      \-      \-      \-       *seh*                   \-
  114        GTCA       \+       \+       \+      \+       \+       \+            \-           \+      \-      \+      \-      \-       *seh*                   \-
  115        GTR^VI^    \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       \-                      \-
  116        GTR^VI^    \+       \+       \+      \+       \+       \+            \-           \-      \+      \-      \-      \-       \-                      \-
  117        GTR^VI^    \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       \-                      \-
  118        GTR^VI^    \+       \+       \+      \+       \+       \+            \-           \-      \-      \-      \-      \-       \-                      \-
  119        GTCB       \+       \+       \+      \+       \+       \+            \-           \+      \+      \-      \-      \-       \-                      \-
  120        GTR^VI^    \+       \+       \+      \+       \+       \-            \-           \+      \+      \+      \-      \-       \-                      \-

toxins-10-00247-t010_Table 10

###### 

World survey on *S. aureus* cow isolates: participating countries, total isolates analyzed per country, number of isolated from clinical mastitis or high somatic cell count (H) samples, and type of sample collection (C = composite milk sample; Q = quarter milk sample).

  Country                    Total Isolates Analyzed per Country             
  -------------------------- ------------------------------------- ---- ---- ---
  **Argentina**              16                                         10   C
  **Brazil**                 15                                         12   Q
  **Colombia**                                                     15   11   Q
  **Germany**                17                                         17   Q
  **Italy**                  17                                         15   Q
  **New York State (USA)**   17                                         13   Q
  **South Africa**           11                                         9    Q
  **Tunisia**                                                      12   10   C
  **Total**                  93                                    27   97   

toxins-10-00247-t011_Table 11

###### 

Primer used in this study for *S. aureus* isolates characterization.

  Target Gene                             Primer Sequence (5′-3′)          Amplification Size   Reference
  --------------------------------------- -------------------------------- -------------------- ----------------------------
  Invasion                                                                                      
  *clf*A                                  GGCTTCAGTGCTTGTAGG               1000 bp              \[[@B42-toxins-10-00247]\]
                                          TTTTCAGGGTCAATATAAGC                                  
  *coa*                                   CCGCTTCAACTTCAGCCTAC             204 bp               \[[@B43-toxins-10-00247]\]
                                          TTAGGTGCTACAGGGGCAAT                                  
  *nuc*                                   AGTTCAGCAAATGCATCACA             400 bp               \[[@B43-toxins-10-00247]\]
                                          TAGCCAAGCCTTGACGAACT                                  
  *luk*E                                  AATGTTAGCTGCAACTTTGTCA           831 bp               \[[@B22-toxins-10-00247]\]
                                          CTTTCTGCGTAAATACCAGTTCTA                              
  *luk*M                                  TGGATGTTACCTATGCAACCTAC          780 bp               \[[@B44-toxins-10-00247]\]
                                          GTTCGTTTCCATATAATGAATCACTAC                           
  *luk*E-*luk*D                           TGAAAAAGGTTCAAAGTTGATACGAG       269 bp               \[[@B44-toxins-10-00247]\]
                                          TGTATTCGATAGCAAAAGCAGTGCA                             
  *lukSF-PV*                              ATCATTAGGTAAAATGTCTGGACATGATCA   433 bp               \[[@B45-toxins-10-00247]\]
                                          GCATCAAGTGTATTGGATAGCAAAAGC                           
  *scn*                                   ATACTTGCGGGAACTTTAGCAA           320 bp               \[[@B10-toxins-10-00247]\]
                                          TTTTAGTGCTTCGTCAATTTCG                                
  *chp*                                   TTTTTAACGGCAGGAATCAGTA           404 bp               \[[@B10-toxins-10-00247]\]
                                          TGCATATTCATTAGTTTTTCCAGG                              
  *fmtB*                                  AATGAAGATGCGAATCATGTTG           725 bp               \[[@B10-toxins-10-00247]\]
                                          CATCCATTTTTGTTTGCGTAGA                                
  *sak*                                   TGAGGTAAGTGCATCAAGTTCA           403 bp               \[[@B10-toxins-10-00247]\]
                                          CCTTTGTAATTAAGTTGAATCCAGG                             
  *cna*                                   AAAGCGTTGCCTAGTGGAGA             192 bp               \[[@B46-toxins-10-00247]\]
                                          AGTGCCTTCCCAAACCTTTT                                  
  Interfere with host defense mechanism                                                         
  *tsst*                                  ATGGCAGCATCAGCTTGATA             300 bp               \[[@B42-toxins-10-00247]\]
                                          TTTCCAATAACCACCCGTTT                                  
  *eta*                                   CTAGTGCATTTGTTATTCAA             120 bp               \[[@B42-toxins-10-00247]\]
                                          TGCATTGACACCATAGTACT                                  
  *etb*                                   ACGGCTATATACATTCAATT             200 bp               \[[@B42-toxins-10-00247]\]
                                          TCCATCGATAATATACCTAA                                  
  *sea*                                   TAAGGAGGTGGTGCCTATGG             180 bp               \[[@B43-toxins-10-00247]\]
                                          CATCGAAACCAGCCAAAGTT                                  
  *seb*                                   TCGCATCAAACTGACAAACG             478 bp               \[[@B44-toxins-10-00247]\]
                                          GCAGGTACTCTATAAGTGCC                                  
  *sec*                                   ACCAGACCCTATGCCAGATG             371 bp               \[[@B43-toxins-10-00247]\]
                                          TCCCATTATCAAAGTGGTTTCC                                
  *sed*                                   TCAATTCAAAAGAAATGGCTCA           339 bp               \[[@B43-toxins-10-00247]\]
                                          TTTTTCCGCGCTGTATTTTT                                  
  *see*                                   TACCAATTAACTTGTGGATAGAC          170 bp               \[[@B47-toxins-10-00247]\]
                                          CTCTTTGCACCTTACCGC                                    
  *seg*                                   CCACCTGTTGAAGGAAGAGG             432 bp               \[[@B43-toxins-10-00247]\]
                                          TGCAGAACCATCAAACTCGT                                  
  *seh*                                   TCACATCATATGCGAAAGCAG            463 bp               \[[@B43-toxins-10-00247]\]
                                          TCGGACAATATTTTTCTGATCTTT                              
  *sei*                                   CTCAAGGTGATATTGGTGTAGG           529 bp               \[[@B43-toxins-10-00247]\]
                                          CAGGCAGTCCATCTCCTGTA                                  
  *sej*                                   GGTTTTCAATGTTCTGGTGGT            306 bp               \[[@B43-toxins-10-00247]\]
                                          AACCAACGGTTCTTTTGAGG                                  
  *sel*                                   CACCAGAATCACACCGCTTA             240 bp               \[[@B43-toxins-10-00247]\]
                                          CTGTTTGATGCTTGCCATTG                                  
  Antibiotic resistance                                                                         
  *mecA*                                  GTAGAAATGACTGAACGTCCGATAA        310 bp               \[[@B45-toxins-10-00247]\]
                                          CCAATTCCACATTGTTTCGGTCTAA                             
